Novartis (NVS) and Roche executives are due to meet with Swiss government officials this week as President Donald Trump urges pharmaceutical firms to lower their prices in the US, Reuters reported Monday, citing two sources.
Economy Minister Guy Parmelin and Health Minister Elizabeth Baume-Schneider will meet with executives of the two drug makers as well as other companies, the sources told the news outlet.
Switzerland is aiming to negotiate with the US to lower the 39% tariffs announced on its exports, according to the report.
The discussions may also be about encouraging the drug makers to invest more in the US and reduce Switzerland's trade surplus with the country, which could help lower the tariffs, a source familiar with the matter told Reuters.
Novartis and Roche did not immediately reply to requests for comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 117.82, Change: +0.97, Percent Change: +0.83
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.